Aims and Scope of Pharmacology and Therapeutics
Pharmacology & Therapeutics is a medical review journal published by Elsevier. It incorporates Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors and Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology, both originally published by Oxford University Press. Less
Key Metrics
CiteScore 

22.2
Eigenfactor 

0.01 - 0.05
Impact Factor 

10 - 15
SJR 

Q1Pharmacology

SNIP 

2.93
Recommended pre-submission checks
Powered by 

Topics Covered on Pharmacology and Therapeutics
Pharmacology and Therapeutics Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | PERGAMON-ELSEVIER SCIENCE LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1979 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacology and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pharmacology and Therapeutics
Harnessing multispecific antibodies for next-generation cancer treatments.
- 1 Oct 2026
- Pharmacology & therapeutics
Corrigendum to "Targeting BRD4 to reverse organ fibrosis: Epigenetic regulation, cellular plasticity, and therapeutic potential" [Pharmacology & Therapeutics, Volume 285, 2026, 109055
- 1 Oct 2026
- Pharmacology & therapeutics
Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring.
- 1 Oct 2026
- Pharmacology & therapeutics
Metabolic reprogramming in pulmonary arterial hypertension.
- 1 Oct 2026
- Pharmacology & therapeutics
Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations.
- 1 Oct 2026
- Pharmacology & therapeutics
Neurotheranostics in Alzheimer's Disease: Current concepts and experimental strategies.
- 1 Oct 2026
- Pharmacology & therapeutics
Harnessing multispecific antibodies for next-generation cancer treatments.
- 1 Oct 2026
- Pharmacology & therapeutics
Corrigendum to "Targeting BRD4 to reverse organ fibrosis: Epigenetic regulation, cellular plasticity, and therapeutic potential" [Pharmacology & Therapeutics, Volume 285, 2026, 109055
- 1 Oct 2026
- Pharmacology & therapeutics
Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring.
- 1 Oct 2026
- Pharmacology & therapeutics
Metabolic reprogramming in pulmonary arterial hypertension.
- 1 Oct 2026
- Pharmacology & therapeutics
Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations.
- 1 Oct 2026
- Pharmacology & therapeutics
Neurotheranostics in Alzheimer's Disease: Current concepts and experimental strategies.
- 1 Oct 2026
- Pharmacology & therapeutics